Washington Trust Advisors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-67
Closed -$4.97K 635
2025
Q3
$4.97K Buy
67
+28
+72% +$2.83K ﹤0.01% 618
2025
Q2
$5.06K Hold
39
﹤0.01% 568
2025
Q1
$6.21K Hold
39
﹤0.01% 530
2024
Q4
$7.23K Hold
39
﹤0.01% 521
2024
Q3
$8.23K Sell
39
-13
-25% -$2.26K ﹤0.01% 505
2024
Q2
$6.96K Hold
52
﹤0.01% 517
2024
Q1
$11.2K Hold
52
﹤0.01% 468
2023
Q4
$10.6K Buy
52
+14
+37% +$2.27K ﹤0.01% 464
2023
Q3
$7.54K Hold
38
﹤0.01% 505
2023
Q2
$12.3K Hold
38
﹤0.01% 429
2023
Q1
$8.89K Sell
38
-7
-16% -$1.77K ﹤0.01% 513
2022
Q4
$11.3K Hold
45
﹤0.01% 484
2022
Q3
$8K Hold
45
﹤0.01% 636
2022
Q2
$8K Sell
45
-10
-18% -$1.99K ﹤0.01% 664
2022
Q1
$14K Hold
55
﹤0.01% 659
2021
Q4
$13K Buy
+55
New +$13.4K ﹤0.01% 694

Other funds holding INSP

Washington Trust Advisors's INSP Position: Q4 2025 in Review

Washington Trust Advisors sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 67 shares — an estimated $4.97K sold.

Washington Trust Advisors first reported a position in INSP in Q4 2021 and held it in 16 quarters. The position peaked at $14K in Q1 2022. 342 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • Washington Trust Advisors reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 67 Inspire Medical Systems shares in Q4 2025, an estimated $4.97K.
  • Washington Trust Advisors first reported a position in Inspire Medical Systems in Q4 2021 and held it in 16 quarters.
  • Washington Trust Advisors's Inspire Medical Systems position peaked at $14K in Q1 2022.
  • 342 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.